PDF(Pubmed)
Abstract：
Authorship in clinical trials and clinical practice guidelines is considered prestigious and is associated with broader peer recognition. This systematic review investigated female representation among studies reporting authorship trends in clinical trials or clinical practice guidelines in different medicine subspecialties. Our search strategy yielded 836 articles, of which 30 met the inclusion criteria. Our findings indicate that females are severely underrepresented in authorship of clinical trials and clinical practice guidelines. Although the proportions of females may have improved in the past decade, the gains are marginal. Notably, studies in this domain predominantly focus on first/last authorship positions, and whether females are underrepresented in other positions as collaborative partners is currently unknown. Also, authorship trends in clinical trials or clinical practice guidelines of most medicine subspecialties besides cardiovascular medicine remain under-researched. Hence, standardizing the methodology for studying gender disparity in research output for comparative analysis between different subspecialties is as urgent as addressing the gender disparity in authorship.
摘要：
临床试验和临床实践指南中的作者身份被认为是享有盛誉的，并且与更广泛的同行认可有关。本系统综述调查了报告不同医学亚专业临床试验或临床实践指南中作者身份趋势的研究中的女性代表。我们的搜索策略产生了836篇文章，其中30人符合纳入标准。我们的发现表明，女性在临床试验和临床实践指南的作者中代表性严重不足。尽管女性的比例在过去十年中可能有所改善，收益是边际的。值得注意的是,该领域的研究主要集中在第一/最后作者职位上，目前尚不清楚女性在其他合作伙伴职位上的代表性是否不足。此外，除心血管医学外，大多数医学亚专业的临床试验或临床实践指南的作者趋势仍未得到充分研究。因此，标准化研究产出中性别差异的方法，以进行不同亚专业之间的比较分析，与解决作者身份中的性别差异一样紧迫。
